Alcyone Therapeutics
Maurizio Pellechia is on the Board of Advisors at Alcyone Therapeutics. Maurizio is also the Director, Center for Molecular and Translational Medicine at University of California, Riverside.
This person is not in the org chart
This person is not in any offices
Alcyone Therapeutics
Alcyone Therapeutics is a biotechnology company pioneering next-generation precision central nervous system (CNS) therapies to improve the lives of patients and families impacted by severe neurological conditions. Alcyone Therapeutics is advancing a pipeline of adeno-associated virus (AAV) gene therapy programs that leverage its proprietary, next-generation CNS delivery technology platform. Alcyone Therapeutics’ lead programs target the treatment of Rett syndrome and spinal muscular atrophy with respiratory distress type 1 (SMARD1).